Item 4 of the Original Statement is hereby amended by deleting the heading "Convertible Notes" and the two paragraphs thereunder and replacing them with the following: Consummation of Debt Exchange, Convertible Notes, Indenture and Note Registration Rights Agreement On December 16, 2025, the Issuer's stockholders approved the Debt Exchange, the Forbearance Warrant Excess Shares Issuance and the Additional Notes Issuance. On December 18, 2025, the Issuer and Dialectic consummated the transactions contemplated by the Transaction Agreement, including the Debt Exchange. Upon the Closing, (a) the Issuer issued to Dialectic, on a dollar-for-dollar basis, Convertible Notes in an aggregate principal amount of $54,718,114 for the amounts then outstanding and owing by the Issuer to Dialectic under the Term Loans (including principal, any prepayment penalties and exit fees, but excluding any accrued and unpaid interest thereon) and (b) entered into the Indenture governing the Convertible Notes with U.S. Bank Trust Company, National Association, as trustee and collateral agent. The Convertible Notes mature December 18, 2028 (the "Maturity Date") and have an interest rate of 10.00% per annum, payable in kind, compounded annually, and are secured by all of the assets of the Issuer currently securing the Term Loans. The initial conversion price of the Convertible Notes equals $10.00 per share (the "Conversion Price") of Common Stock, subject to adjustment for stock splits and similar events, and includes antidilution protections in favor of Dialectic as described in the Indenture. The Conversion Price is subject to adjustment on the last day of the three calendar quarters immediately following the Closing (each, a "Reset Price Date") to the greater of (a) $4.00 per share and (b) the lesser of (i) the then Conversion Price and (ii) the 30-day Daily VWAP (as defined in the Indenture) of the Common Stock immediately preceding the Reset Price Date. Based on the Conversion Price as of the Closing Date, the Convertible Notes were convertible into 5,471,811 shares of Common Stock. At the Issuer's option, all outstanding principal amount, accrued and unpaid interest and premium, if any, of any Convertible Notes outstanding on the Maturity Date shall be exchanged into shares of Common Stock at an exchange price equal to 80% of the Market Price, defined as the average of the Daily VWAP for each of the five lowest consecutive trading days during the 20 consecutive trading days ending on (and including) the trading day immediately prior to the Maturity Date. Following the six-month anniversary of Closing, if certain conditions are met, the Issuer may elect to require the exchange of a portion of the total outstanding amount of any Convertible Notes into shares of Common Stock at the then outstanding Conversion Price. The Indenture contains certain affirmative and negative covenants substantially consistent with the Fifteenth Term Loan Amendment, as well as a covenant requiring the Issuer to maintain minimum liquidity of $3.75 million as of the last day of the first quarter of 2026, $5.0 million as of the last day of the second quarter of 2026, $6.25 million as of the last day of the third quarter of 2026 and $7.5 million as of the last day of the fourth quarter of 2026 and each quarter thereafter. In addition, at the Closing, the Issuer and Dialectic entered into a registration rights agreement (the "Note Registration Rights Agreement") pursuant to which, among other things, the Issuer will provide Dialectic (or any assignee of the Convertible Notes) with certain demand and piggyback registration rights with respect to the shares of Common Stock issuable upon any conversion of the Convertible Notes. In connection with the issuance of the Convertible Notes, on December 22, 2025, Dialectic delivered to the Issuer a waiver of the limitation on exercise of the Forbearance Warrant that would prevent exercise of the Forbearance Warrant to the extent that Dialectic, its affiliates and any other persons whose beneficial ownership of Common Stock would be aggregated with Dialectic's for purposes of Section 13(d) of the Securities Exchange Act of 1934 would beneficially own in excess of 4.99% or, under certain circumstances, 19.99% of the total number of issued and outstanding shares of Common Stock. Such waiver will be effective on February 21, 2026, from and after which date the Forbearance Warrant will be exercisable in full without regard to such limitation.